---
productSlug: ensure
companySlug: abbott-laboratories
generatedOn: 2026-05-26
---

# Build A Free Alternative To Abbott Laboratories's Ensure

You are turning a disruptive product thesis into a real project. Treat this as an execution brief for Codex, Claude, OpenCode/OpenClaw, or another capable coding agent.

## Product Context

- Company: Abbott Laboratories (ABT)
- Company slug: abbott-laboratories
- Company description: Abbott Laboratories makes medical devices, diagnostics, nutrition products, and branded generic medicines.
- Product: Ensure
- Product slug: ensure
- Product category: Adult nutrition shakes and supplements
- Product homepage: https://www.ensure.com/
- Product summary: Ensure is Abbott's adult nutrition brand, offering shakes and supplements aimed at protein, calorie, vitamin, and specialty nutrition use cases.
- Why it matters: Branded nutrition products sit at the intersection of consumer trust, clinical recommendations, ingredient sourcing, retail distribution, and label transparency.

## Company Thesis

- Business mix
  Abbott operates across medical devices, diagnostics, nutrition, and established pharmaceuticals, giving it a diversified health-care revenue base rather than a single-drug patent cycle.
  The FreeStyle Libre diabetes-care platform and adult nutrition brands such as Ensure illustrate Abbott's mix of regulated device ecosystems and branded consumable products.
- Registry posture
  Abbott is a large, regulated incumbent with meaningful clinical, manufacturing, distribution, brand, and reimbursement advantages.
  The most credible decentralization pressure is not a near-term clone of Abbott's regulated products, but open data, interoperable care infrastructure, cooperative nutrition formulation, and user-controlled monitoring layers around the products.

### Moat narrative
- Abbott's moat is strongest where regulated clinical evidence, quality systems, reimbursement relationships, clinician trust, manufacturing scale, and brand familiarity compound. Continuous glucose monitoring and medical nutrition are not simple software markets; safety, compliance, distribution, and patient trust all matter.
- The moat is not absolute. Open-source diabetes data tools show that motivated patients can build user-controlled monitoring and automation layers around commercial sensors, while open nutrition data can make product comparison and formulation more transparent.

### Decentralization narrative
- Abbott's physical products remain difficult to decentralize because sensors, diagnostics, nutrition manufacturing, labeling, and medical claims are heavily regulated and quality-sensitive. That limits near-term substitution by informal open projects.
- The decentralizable layers are coordination and information: patient-controlled CGM data stores, open artificial-pancreas software, open food databases, cooperative purchasing, and transparent formulation networks that reduce dependence on a single branded interface or nutrition label.

## Replacement Sketch

- A free-world replacement is more likely to be an open formulation and verification network than a single competing brand: transparent recipes, open nutrition databases, cooperative ingredient purchasing, and local production partners.
- For medically vulnerable users, replacement has to respect dietitian oversight, allergen controls, and manufacturing quality rather than treating nutrition shakes as generic consumer smoothies.

## Existing Alternatives Worth Studying First

- Open Food Facts (open-source): Open Food Facts is an open food-product database and API that can support nutrition comparison, ingredient transparency, and community verification around packaged foods.. Homepage: https://world.openfoodfacts.org/. Repo: https://github.com/openfoodfacts/openfoodfacts-server.

## Relevant Technology Waves

- Microfactories and automated mini-home production: Small, software-defined manufacturing cells could make localized production less eccentric and more default.

## Useful Sources To Read Before Building

- Abbott 2025 Annual Report (Abbott Laboratories) - https://www.abbottinvestor.com/static-files/0a0ae355-efb5-4023-bd8f-fc4e43f98877
  Why it matters: Primary annual-report source for Abbott's business segments, performance context, and nutrition and medical-device discussion.
- Abbott Laboratories Market Cap (StockAnalysis) - https://stockanalysis.com/stocks/abt/market-cap/
  Why it matters: Market-data source reporting Abbott's market capitalization near the May 2026 snapshot date.
- Abbott Laboratories P/E Ratio (CompaniesMarketCap) - https://companiesmarketcap.com/abbott-laboratories/pe-ratio/
  Why it matters: Market-data source for Abbott's May 2026 trailing P/E ratio and public-company valuation context.
- Abbott Products and Solutions List (Abbott Laboratories) - https://www.abbott.com/en-us/products-solutions/product-list
  Why it matters: Official product list showing Abbott's major product areas and references to FreeStyle Libre and Ensure.
- Open Food Facts API Documentation (Open Food Facts) - https://openfoodfacts.github.io/documentation/docs/Product-Opener/api/
  Why it matters: Documentation for the Open Food Facts API, used as evidence for open nutrition-product data and contribution workflows.

## Required Operating Workflow

1. Start by asking the user whether they already have a repository for this project.
2. If they do not have a repository yet, ask which platform they want to use.
3. If the user wants a new repository and a suitable CLI is installed and authenticated, offer to create it on their behalf.
4. Prefer `gh` for GitHub when available, but support another installed platform CLI if that is what the user is using.
5. Do not assume repository ownership, visibility, or naming. Ask first, then act.

## Required Build Sequence

1. Restate the target: build a free, open, decentralized, cooperative, or protocol-first alternative that creates real pressure on Abbott Laboratories's Ensure business.
2. Before writing implementation code, research and document the enabling protocols, interfaces, standards, and coordination mechanisms this product should rely on.
3. Produce the high-level docs first. At minimum create:
   - a `README.md` with the product thesis and scope;
   - a `docs/architecture.md` describing the system shape;
   - a `docs/protocols.md` describing APIs, protocols, data contracts, or higher-level coordination documents;
   - a `docs/research.md` summarizing incumbent assumptions, alternatives, and what the project will deliberately not do yet.
4. If the right answer is initially a protocol spec, design document, or interface contract instead of running code, do that first and make the repo reflect it.
5. Only after the docs and protocols are coherent should implementation begin.

## Bright Builds Requirement Adoption

Adopt the Bright Builds coding and architecture requirements very early, before significant implementation work.

Repository:
- [bright-builds-llc/coding-and-architecture-requirements](https://github.com/bright-builds-llc/coding-and-architecture-requirements)

Primary references:
- [README](https://github.com/bright-builds-llc/coding-and-architecture-requirements)
- [AI-ADOPTION.md](https://raw.githubusercontent.com/bright-builds-llc/coding-and-architecture-requirements/main/AI-ADOPTION.md)

Follow this exact decision flow:

1. Confirm you are in the root of the downstream repository.
2. Run:

```bash
curl -fsSL https://raw.githubusercontent.com/bright-builds-llc/coding-and-architecture-requirements/main/scripts/manage-downstream.sh | bash -s -- status
```

3. If status reports `Repo state: installable`, run:

```bash
curl -fsSL https://raw.githubusercontent.com/bright-builds-llc/coding-and-architecture-requirements/main/scripts/manage-downstream.sh | bash -s -- install --ref main
```

4. If status reports `Repo state: installed`, run:

```bash
curl -fsSL https://raw.githubusercontent.com/bright-builds-llc/coding-and-architecture-requirements/main/scripts/manage-downstream.sh | bash -s -- update --ref main
```

5. If status reports `Repo state: blocked`, stop and explain the blocking files instead of forcing replacement automatically.
6. Only use `install --force` if the user explicitly asks to replace blocked managed files.
7. After installation or update, mention `coding-and-architecture-requirements.audit.md` as the paper trail.

## Parallel Research Expectations

If your environment supports subagents, spawn bounded parallel subagents early for:

- protocol and standards research;
- incumbent and alternative product research;
- repo/bootstrap and requirements adoption;
- architecture and system design;
- implementation planning and test strategy.

If your environment does not support subagents, still execute those tracks explicitly in sequence and preserve the same separation of concerns.

## Implementation Expectations

After the docs and protocols are settled:

1. Choose the smallest credible first release shape: protocol/spec only, backend service, web app, full-stack app, or another justified structure.
2. Implement the project on top of the documented contracts instead of improvising ad hoc interfaces mid-build.
3. Prefer root-cause design over shallow feature imitation.
4. Keep the repo production-shaped early: clear module boundaries, tests, verification commands, and documented assumptions.
5. If the project should expose APIs, formalize request/response contracts and error behavior before broad feature work.

## Required Deliverables

Produce all of the following unless the user narrows scope:

- repository bootstrap or repository-creation outcome;
- Bright Builds requirements adoption outcome;
- protocol and interface research summary;
- high-level docs and architecture docs;
- initial implementation plan with milestones or phases;
- working implementation of the first meaningful slice;
- tests and verification evidence;
- explicit residual risks and next steps.

## Done Criteria

Do not declare completion until:

- the docs and protocol decisions are written down;
- the implementation matches those decisions or explains the deviation;
- relevant tests, lint, type checks, and build steps have run, or there is a concrete reason they could not run;
- the user has a clear path to continue shipping the project.
